Table 1.

Clinical and Demographic Characteristics of Study Participants

Study population	N = 32 subjects participating in ACTG 5244
Age (median, range)	52 (35–71) years
Sex (female/male ratio)	3 female, 29 male
Median plasma HIV-1 RNA (25%, 75% percentile) (determined by single-copy assay)	1.5 copies/mL (0.6–4 copies/mL)
Median CD4 T cell count (25%, 75% percentile)	569 cells/µL (443–733 cells/µL)
Prestudy ART regimen	11 Protease inhibitor-based
	21 NNRTI-based
Race/ethnicity	Black non-Hispanic: 7
	Hispanic: 4
	White non-Hispanic: 21

Abbreviations: ACTG, AIDS Clinical Trials Group; ART, antiretroviral therapy; HIV, human immunodeficiency virus; NNRTI, nonnucleoside reverse-transcriptase inhibitor.